ArriVent BioPharma, Inc. (AVBP) vs Anteris Technologies Global Corp. (AVR)
A side-by-side comparison of ArriVent BioPharma, Inc. and Anteris Technologies Global Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVBP
ArriVent BioPharma, Inc.
$14.45HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
AVR
Anteris Technologies Global Corp.
$7.18HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
Total return — AVBP vs AVR
growth of $100 · dividends reinvested · last 2yAVBP +6.5% (+3.2%/yr)AVR +34.8% (+16.1%/yr)AVR compounded faster over this window
AVBP AVR
AVBP vs AVR: by the numbers
- •AVR is the larger company ($698M vs $673M market cap).
- •Both run net losses; AVBP's is the smaller (0.00% vs -4619.67% net margin).
Metrics side by side
Valuation
| Metric | AVBP | AVR |
|---|---|---|
| P/S ratio | N/A | 311.39 |
| P/B ratio | 1.83 | 2.78 |
Profitability
| Metric | AVBP | AVR |
|---|---|---|
| Gross margin | 0.00% | -16.57% |
| Operating margin | 0.00% | -4908.21% |
| Net margin | 0.00% | -4619.67% |
| ROE | -44.63% | -41.20% |
| ROIC | -47.96% | -41.63% |
Growth (annualized)
| Metric | AVBP | AVR |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -18.92% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.